Aldesleukin Completed Phase 2 Trials for Acute Lymphoblastic Leukaemias (ALL) / Myelodysplastic Syndrome / Non-Hodgkin's Lymphoma (NHL) / Myeloproliferative Disorders / Lymphoma, Hodgkins / chronic Chronic myelogenous leukemia / All / Leukemia Acute Myeloid Leukemia (AML) / Non-malignant Diseases Requiring Allogeneic HSCT Treatment